A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market.

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Selon un communiqué de presse, la pilule antidiabétique Rybelsus de la société pharmaceutique danoise Novo Nordisk réduit le ...

Xavier Renaud, un garçon de Bellechasse aux prises avec une déficience génétique extrêmement rare, aura droit à encore trois ...

Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...

As a federal crackdown on Ozempic-style copycats looms, Hims is trying a unique new strategy to lobby lawmakers.

Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...

Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...

Novo Nordisk a présenté les résultats complets de STRIDE, un essai de phase 3b sur les résultats de la maladie artérielle ...